Liver Injury
FDA reports Samsca may cause liver damage
(HealthDay)—After reviewing data from recent large clinical trials, the U.S. Food and Drug Administration has determined that Samsca (tolvaptan) should not be used for longer than 30 days and should not ...
Medications
May 02, 2013 |
not rated yet |
0
New research shows weekend binge drinking could leave lasting liver damage
Long after a hangover, a night of bad decisions might take a bigger toll on the body than previously understood. Described in the current issue of Alcoholism: Clinical & Experimental Research, a study at the University of Missouri has revealed a ...
Health
May 01, 2013 |
not rated yet |
0
Frequently used biologic agents might cause acute liver injury
A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journa ...
Diseases, Conditions, Syndromes
Apr 29, 2013 |
not rated yet |
0
Sunshine hormone, vitamin D, may offer hope for treating liver fibrosis
Liver fibrosis results from an excessive accumulation of tough, fibrous scar tissue and occurs in most types of chronic liver diseases. In industrialized countries, the main causes of liver injury leading ...
Medical research
Apr 25, 2013 |
5 / 5 (1) |
0
|
Dietary medium chain triglycerides prevent nonalcoholic fatty liver disease
Scientists at the Arkansas Children's Nutrition Center, a U.S. Department of Agriculture Agricultural Research Service Human Nutrition Research Center at the University of Arkansas for Medical Sciences, led by Dr. Martin ...
Diseases, Conditions, Syndromes
Apr 24, 2013 |
5 / 5 (1) |
0
Vitamin E identified as potential weapon against obesity
A potential new way to fight obesity-related illness has been uncovered, thanks to serendipitous research led by investigators at the Case Western Reserve University School of Medicine.
Overweight and Obesity
Apr 23, 2013 |
5 / 5 (1) |
0
NIH develops improved mouse model of alcoholic liver disease
(Medical Xpress)—Scientists may be better able to study how heavy drinking damages the liver using a new mouse model of alcohol drinking and disease developed by researchers from the National Institute ...
Medical research
Mar 01, 2013 |
not rated yet |
0
Predicting liver injury in paracetamol overdose patients
Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.
Medications
Feb 22, 2013 |
not rated yet |
0
Hepatic function testing can assist in treatment planning for liver cancer patients
Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during radiation therapy, provides ...
Cancer
Feb 08, 2013 |
not rated yet |
0
FDA: Samsca may cause irreversible liver damage
(HealthDay)—Patients who take Samsca (tolvaptan) may be at elevated risk for significant liver injury, according to a Jan. 25 safety alert issued by the U.S. Food and Drug Administration.
Medications
Jan 26, 2013 |
not rated yet |
0
Binge drinking can dramatically amplify damage to the liver
Alcoholic liver disease (ALD) is characterized by a fatty liver, hepatitis, fibrosis, and cirrhosis. Binge drinking is on the rise worldwide, and is particularly common in the U.S. A review of studies addressing the effects ...
Addiction
Jan 22, 2013 |
not rated yet |
0
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
DARPA foam could increase survival rate for victims of internal hemorrhaging
The Department of Defense's medical system aspires to a standard known as the "Golden Hour" that dictates that troops wounded on the battlefield are moved to advanced-level treatment facilities within the ...
Medical research
Dec 11, 2012 |
3 / 5 (2) |
0
Dietary supplements can cause liver injury, warns expert
Dose-dependent (acetaminophen) and idiosyncratic drug-induced liver injuries (DILI) are the leading cause of acute liver failure in the United States and are responsible for approximately 50 percent of all reported cases.
Diseases, Conditions, Syndromes
Oct 29, 2012 |
not rated yet |
0
NIH launches free database of drugs associated with liver injury
A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available ...
Diseases, Conditions, Syndromes
Oct 12, 2012 |
3 / 5 (2) |
0
Latest Spotlight News
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Returning genetic incidental findings without patient consent violates basic rights, experts say
Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...
Vicious cycle: Obesity sustained by changes in brain biochemistry
With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...
White matter imaging provides insight into human and chimpanzee aging
(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...
